St, John Providence Health System, Department of Medicine, Cardiology Section, Providence Park Heart Institute, Novi, MI, USA.
BMC Med Imaging. 2011 May 24;11:12. doi: 10.1186/1471-2342-11-12.
Discomfort characterized by pain and warmth are common adverse effects associated with the use of intra-arterial iodinated contrast media (CM). The objective of this review was to pool patient-reported outcomes available from head-to-head randomized controlled trials (RCTs) and to compare the discomfort rates associated with iso-osmolar contrast media (IOCM; i.e., iodixanol) to those reported with various low-osmolar contrast media (LOCM).
A review of the literature published between 1990 and 2009 available through Medline, Medline Preprints, Embase, Biological Abstracts, BioBase, Cab Abstracts, International Pharmaceutical Abstracts, Life Sciences Collection, Inside Conferences, Energy Database, Engineering Index and Technology Collection was performed to compare rates of discomfort associated with the use of the IOCM (iodixanol) vs. various LOCM agents in head-to-head RCTs. All trials with a Jadad score ≥2 that reported patient discomfort data following intra-arterial administration of CM were reviewed, coded, and extracted.
A total of 22 RCTs (n = 8087) were included. Overall discomfort (regardless of severity) was significantly different between patients receiving IOCM and various LOCMs (risk difference [RD] -0.049; 95% confidence interval [CI]: -0.076, -0.021; p = 0.001). IOCM was favored over all LOCMs combined with a summary RD value of -0.188 (95% CI: -0.265, -0.112; p < 0.001) for incidence of pain, regardless of severity. A greater reduction in the magnitude of pain was observed with IOCM (iodixanol), particularly with selective limb and carotid/intracerebral procedures. Similarly, the meta-analysis of warmth sensation, regardless of severity, favored IOCM over LOCMs with an RD of -0.043 (95% CI: -0.074, -0.011; p = 0.008). A positive linear relationship was observed between the discomfort effect size and age and a negative relationship with increasing proportion of women. The opposite trends were observed with warmth sensation.
IOCM was associated with less frequent and severe patient discomfort during intra-arterial administration. These data support differences in osmolality as a possible determinant of CM discomfort.
疼痛和发热是使用动脉内碘造影剂(CM)后常见的不良反应。本研究旨在汇总头对头随机对照试验(RCT)中患者报告的结局数据,并比较等渗造影剂(IOCM;即碘克沙醇)与各种低渗造影剂(LOCM)相关的不适发生率。
检索 1990 年至 2009 年发表在 Medline、Medline 预印本、Embase、生物文摘、生物基础、Cab 摘要、国际药学文摘、生命科学收藏、内部会议、能源数据库、工程索引和技术收藏中的文献,比较 IOCM(碘克沙醇)与各种 LOCM 药物在头对头 RCT 中使用的不适发生率。对所有 Jadad 评分≥2 分、报告 CM 动脉内给药后患者不适数据的试验进行了综述、编码和提取。
共纳入 22 项 RCT(n=8087)。接受 IOCM 和各种 LOCM 治疗的患者总体不适(无论严重程度)差异有统计学意义(风险差[RD]为-0.049;95%置信区间[CI]:-0.076,-0.021;p=0.001)。IOCM 优于所有 LOCM 的汇总 RD 值为-0.188(95%CI:-0.265,-0.112;p<0.001),用于疼痛发生率,无论严重程度如何。与 LOCM 相比,IOCM(碘克沙醇)可显著降低疼痛程度,特别是选择性肢体和颈动脉/颅内手术。同样,无论严重程度如何,对温热感觉的 meta 分析也表明 IOCM 优于 LOCM,RD 为-0.043(95%CI:-0.074,-0.011;p=0.008)。观察到不适效应大小与年龄呈正相关,与女性比例增加呈负相关。而温热感觉则呈现相反的趋势。
IOCM 与动脉内给药时更频繁和更严重的患者不适相关。这些数据支持渗透压差异可能是 CM 不适的决定因素。